Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): A serial intravascular ultrasonography study

European Heart Journal

Volumn 36, Issue 8, 2015, Pages 490-500

  Räber, Lorenz ^a   Taniwaki, Masanori ^a   Zaugg, Serge ^b   Kelbãk, Henning ^c   Roffi, Marco ^d   Holmvang, Lene ^c   Noble, Stephane ^d   Pedrazzini, Giovanni ^e   Moschovitis, Aris ^a   Lüscher, Thomas F ^f   Matter, Christian M ^f   Serruys, Patrick W ^g   Jüni, Peter ^b   Garcia Garcia, Hector M ^g   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY HOSPITAL   (Switzerland)

^e REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g CARDIALYSIS   (Netherlands)

Author keywords

Atherosclerosis; Intravascular Ultrasound; Radiofrequency; ST elevation myocardial infarction; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASUGREL; ROSUVASTATIN; UMIROLIMUS; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; ATHEROMA; BARE METAL STENT; COHORT ANALYSIS; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG ELUTING STENT; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASONOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INFARCT RELATED CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY; RADIOFREQUENCY INTRAVASCULAR ULTRASONOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOSCOPIC ECHOGRAPHY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; ROSUVASTATIN CALCIUM; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84924567285     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu373     Document Type: Article

References (26)

1. Libby P. Mechanisms of acute coronary syndromesand their implications for therapy. N Engl J Med 2013;368:2004-2013.
2. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
3. Nicholls SJ, Brandrup-Wognsen G, Palmer M, Barter PJ. Meta-Analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids. Am J Cardiol 2010;105:69-76.
4. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-1565.
5. Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 2011;365:2078-2087.
6. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'NeillWW. Multiple complex coronary plaques in patients with acute myocardial infarction. NEngl J Med 2000;343:915-922.
7. Hong MK, Mintz GS, LeeCW, Kim YH, LeeSW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004;110:928-933.
8. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, Waring MT, Chicoine AT, van der Laan AM, Niessen HW, Piek JJ, Rubin BB, Butany J, Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, Pittet MJ, Libby P, Lin CP, Swirski FK, Weissleder R, Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature 2012; 487:325-329.
9. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-2206.
10. Nair A, Margolis MP, Kuban BD, Vince DG. Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention 2007;3:113-120.
11. Räber L, Kelbaek H, Ostoijc M, Baumbach A, Tuller D, Von Birgelen C, Roffi M, Pedrazzini G, Kornowski R, Weber K, Heg D, Matter C, Luscher T, Taniwaki M, Meier B, Juni P, Windecker S. Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction: rationale and design. EuroIntervention 2012;7:1435-1443.
12. Räber L, Kelbaek H, Ostojic M, Baumbach A, HegD, Tuller D, vonBirgelen C, Roffi M, Moschovitis A, Khattab AA, Wenaweser P, Bonvini R, Pedrazzini G, Kornowski R, Weber K, Trelle S, Luscher TF, Taniwaki M, Matter CM, Meier B, Juni P, Windecker S. Effect of biolimus-eluting stents with biodegradable polymer vs. baremetal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA 2012;308:777-787.
13. Mintz GS, Garcia-Garcia HM, Nicholls SJ, Weissman NJ, Bruining N, Crowe T, Tardif JC, Serruys PW. Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention 2011;6:1123-1130. 9.
14. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235.
15. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-Analysis of data from 170, 000 participants in 26 randomised trials. Lancet 2010;376:1670-1681.
16. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, KoenigW, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
17. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 2010;55:2399-2407.
18. Serruys PW, Garcia-Garcia HM, Buszman P, Erne P, Verheye S, Aschermann M, Duckers H, Bleie O, Dudek D, Botker HE, Von Birgelen C, D'Amico D, Hutchinson T, Zambanini A, Mastik F, van Es GA, van der Steen AF, Vince DG, Ganz P, Hamm CW, Wijns W, Zalewski A. Effects of the direct lipoprotein-Associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118:1172-1182.
19. Puri R, Libby P, Nissen SE, Wolski K, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Tuzcu EM, Nicholls SJ. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition. Eur Heart J Cardiovasc Imaging 2014;15:380-388.
20. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001;103:926-933.
21. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005;112:563-571.
22. Budoff MJ, Young R, Lopez VA, Kronmal RA, Nasir K, Blumenthal RS, Detrano RC, Bild DE, Guerci AD, Liu K, Shea S, Szklo M, PostW, Lima J, Bertoni A, Wong ND. Progression of coronary calcium and incident coronary heart disease events: MESA. J Am Coll Cardiol 2013;61:1231-1239.
23. Otsuka F, FinnAV, Virmani R.Dovulnerable and ruptured plaques hide in heavily calcified arteries?. Atherosclerosis 2013;229:34-37.
24. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, Inoue K, Okumura M, Ishii J, Anno H, Virmani R, Ozaki Y, Hishida H, Narula J. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007;50:319-326.
25. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW, Virmani R, Muller JE. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007;50: 940-949.
26. Zhao Z, Witzenbichler B, Mintz GS, Jaster M, Choi SY, Wu X, He Y, Margolis MP, Dressler O, Cristea E, Parise H, Mehran R, Stone GW, Maehara A. Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial. JACC Cardiovasc Imaging 2013;6:86-95.